CIRM. 2009d. CIRM, The UK and Canada award more than $250 million to accelerate the pace of bringing stem cell therapies to the clinic: Novel funding mechanism speeds the path of research. http://www.cirm.ca.gov/PressRelease_102809 (accessed August 28, 2012).

CIRM. 2009e. Review summaries for RFA 09-01: Disease team research awards. http://www.cirm.ca.gov/Summaries_RFA_09-01 (accessed September 5, 2012).

CIRM. 2009f. Bylaws of the Scientific and Medical Research Funding Working Group. http://www.cirm.ca.gov/files/PDFs/GWG/GWG_bylaws.pdf (accessed August 28, 2012).

CIRM. 2009g. Conflict of interest policy: Non-ICOC members of the Scientific and Medical Research Funding Working Group. http://www.cirm.ca.gov/reg/pdf/Reg100003_Conflict_of_Interest.pdf (accessed August 28, 2012).

CIRM. 2010a. RFA 10-04: CIRM basic biology awards III. http://www.cirm.ca.gov/RFA_10-04 (accessed August 27, 2012).

CIRM. 2010b. RFA 10-02: CIRM tools and technology awards II. http://www.cirm.ca.gov/RFA_10-02 (accessed August 27, 2012).

CIRM. 2010c. RFA 10-01: CIRM early translational II research awards. http://www.cirm.ca.gov/RFA_10-01 (accessed August 29, 2012).

CIRM. 2010d. RFA 10-03: CIRM targeted clinical development awards. http://www.cirm.ca.gov/RFA_10-03 (accessed August 29, 2012).

CIRM. 2010e. RFA 10-05: CIRM disease team therapy development awards. http://www.cirm.ca.gov/rfa_10-05 (accessed August 29, 2012).

CIRM. 2011a.*Collaborations_CIRM CFPs as of Nov 2011. CIRM’s response to IOM’s data request: list of international organizations/companies that work with CIRM (dated December 2, 2011).

CIRM. 2011b.*Collaborations info re. CFPs productivity evaluation. CIRM’s response to IOM’s data request: provide data about all collaborations from 2006 to the present including origination of the collaboration, nature of the collaboration, how the collaboration was funded and monies spent, how the collaboration was managed (dated December 2, 2011).

CIRM. 2011c. CIRM approves $27 million for initiatives to accelerate promising stem cell research projects. http://www.cirm.ca.gov/PressRelease_2011-12-08 (accessed August 27, 2012).

CIRM. 2011d.*GWG review process for CIRM pre-applications. CIRM’s response to IOM’s data request: Documentation describing the peer review process (dated December 19, 2011).

CIRM. 2011e.*Report on CIRM’s trial pre-application process. CIRM’s response to IOM’s data request: Documentation describing the peer review process (dated December 19, 2011).

CIRM. 2011f. CIRM loan administration policy. http://www.cirm.ca.gov/files/Regulations/LAP.OAL_.REVIEWED.FINAL_.pdf (accessed August 16, 2012).

CIRM. 2011g.*CIRM review process. CIRM’s responses to IOM’s data request: Documentation describing the peer review process (dated December 19, 2011).

CIRM. 2011h. RFA 11-02: CIRM early translational III research awards. http://www.cirm.ca.gov/RFA/rfa-11-02-cirm-early-translational-awards-iii?q=rfa/rfa-11-02-cirm-earlytranslational-awards-iii (accessed August 29, 2012).

CIRM. 2012a. Strategic plan update: Accelerating the opportunity for cures. http://www.cirm.ca.gov/files/PDFs/Publications/2012CIRMstratplan.pdf (accessed August 16, 2012).

CIRM. 2012b. About CIRM. http://www.cirm.ca.gov/about-cirm/ (accessed November 20, 2012).



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement